Skip to content
Search

Latest Stories

Health secretary confirms payment for people on low income whom must self-isolate due to Covid-19

Government will pay low-income residents to self-isolate if they have confirmed or suspected coronavirus as measures have been stepped up to keep the virus under control.

The new policy comes after opposition politicians called on the government to introduce the payments amid concerns that some people who cannot not afford to take time off work were avoiding complying with the health advice.


The government said individuals who test positive for the virus will receive 130 pounds for their 10-day period of self-isolation. Other members of their household, who have to self-isolate for 14 days, will be entitled to 182 pounds.

The money will be available to people on welfare payments known as Universal Credit or Working Tax Credits, and who are unable to work from home. The scheme will be trialed first in Blackburn, Pendle and Oldham, which had experienced local lockdowns because of their higher rates of the virus.

"The British public have already sacrificed a great deal to help slow the spread of the virus. Self-isolating if you have tested positive for Covid-19, or have come into contact with someone who has, remains vital to keeping on top of local outbreaks,” said Matt Hancock, the health secretary.

“This new payment scheme will help people on low incomes and who are unable to work from home to continue playing their part in the national fight against this virus.”

The United Kingdom has suffered more than 65,000 excess deaths from coronavirus, according to the Office for National Statistics, with a surge that lasted longer and spread to more places than those in other hard-hit European nations like Italy and Spain.

More For You

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less